ePrints

Teratogenic drugs - Part 1

Lookup NU author(s): Dr Patricia McElhatton

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

The risks and benefits of drug therapy in pregnancy remain difficult to evaluate. This article, in two parts, sets out some general principles of teratogenesis and prescribing in pregnancy, lists drugs known to be fetotoxic or teratogenic, and describes the specific problems that occur with drugs acting on the central nervous system. These include facial dysmorphism and neural tube defects with anticonvulsant drugs; potential cardiac defects with lithium; and possible withdrawal syndromes with antidepressant drugs. © 2002 Lippincott Williams & Wilkins.

Publication metadata

Author(s): McElhatton P

Publication type: Review

Publication status: Published

Journal: Adverse Drug Reaction Bulletin

Year: 2002

Issue: 213

Pages: 815-818

ISSN (print): 0044-6394

ISSN (electronic):

URL: http://dx.doi.org/10.1097/00012995-200204000-00001

DOI: 10.1097/00012995-200204000-00001

Share